| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |